SPRR2A and thyroid cancer: Excessive activation of 5–LOX, 12–LOX, and 15–LOX in HT may lead to increased pro–inflammatory eicosanoids such as 5S–HETE, 12S–HETE, 15S–HETE, and 5–oxo–ETE, which may contribute to thyroid cancer development.